Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ida Rasmusson

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Experimental Cell Research|April 25, 2006
Immune modulation by mesenchymal stem cellsIda Rasmusson
Experimental Cell Research|March 22, 2005
Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanismsIda Rasmusson, Olle Ringdén, Berit Sundberg, et al.
Journal of Leukocyte Biology|July 5, 2007
Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytesIda Rasmusson, Michael Uhlin, Katarina Le Blanc, et al.
Transplantation|October 28, 2003
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cellsIda Rasmusson, Olle Ringdén, Berit Sundberg, et al.
Upsala Journal of Medical Sciences|November 6, 2010
Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantationIda Rasmusson Duprez, Ulrika Johansson, Bo Nilsson, et al.
Cytotherapy|October 15, 2010
Fetal and adult multipotent mesenchymal stromal cells are killed by different pathwaysCecilia Götherström, Andreas Lundqvist, Ida Rasmusson Duprez, et al.
Lancet (London, England)|May 4, 2004
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cellsKatarina Le Blanc, Ida Rasmusson, Berit Sundberg, et al.
Diabetes|June 4, 2008
Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularizationUlrika Johansson, Ida Rasmusson, Simone P Niclou, et al.
Transplantation|May 30, 2006
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host diseaseOlle Ringdén, Mehmet Uzunel, Ida Rasmusson, et al.
Plos One|July 13, 2011
Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responsesGuido Moll, Regina Jitschin, Lena von Bahr, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Experimental Cell Research|April 25, 2006
Immune modulation by mesenchymal stem cellsIda Rasmusson
Experimental Cell Research|March 22, 2005
Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanismsIda Rasmusson, Olle Ringdén, Berit Sundberg, et al.
Journal of Leukocyte Biology|July 5, 2007
Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytesIda Rasmusson, Michael Uhlin, Katarina Le Blanc, et al.
Transplantation|October 28, 2003
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cellsIda Rasmusson, Olle Ringdén, Berit Sundberg, et al.
Upsala Journal of Medical Sciences|November 6, 2010
Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantationIda Rasmusson Duprez, Ulrika Johansson, Bo Nilsson, et al.
Cytotherapy|October 15, 2010
Fetal and adult multipotent mesenchymal stromal cells are killed by different pathwaysCecilia Götherström, Andreas Lundqvist, Ida Rasmusson Duprez, et al.
Lancet (London, England)|May 4, 2004
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cellsKatarina Le Blanc, Ida Rasmusson, Berit Sundberg, et al.
Diabetes|June 4, 2008
Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularizationUlrika Johansson, Ida Rasmusson, Simone P Niclou, et al.
Transplantation|May 30, 2006
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host diseaseOlle Ringdén, Mehmet Uzunel, Ida Rasmusson, et al.
Plos One|July 13, 2011
Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responsesGuido Moll, Regina Jitschin, Lena von Bahr, et al.
Pageof 2